Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueTax ProvisionsTax Rate
Others
Ratios

Acadia Healthcare Company (ACHC) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Acadia Healthcare Company (ACHC) over the last 16 years, with Q3 2025 value amounting to $811.6 million.

  • Acadia Healthcare Company's Operating Expenses rose 1318.16% to $811.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 billion, marking a year-over-year increase of 1407.22%. This contributed to the annual value of $2.8 billion for FY2024, which is 480.74% down from last year.
  • Acadia Healthcare Company's Operating Expenses amounted to $811.6 million in Q3 2025, which was up 1318.16% from $819.2 million recorded in Q2 2025.
  • Acadia Healthcare Company's 5-year Operating Expenses high stood at $1.0 billion for Q3 2023, and its period low was $497.4 million during Q4 2021.
  • For the 5-year period, Acadia Healthcare Company's Operating Expenses averaged around $654.2 million, with its median value being $634.9 million (2023).
  • As far as peak fluctuations go, Acadia Healthcare Company's Operating Expenses surged by 8217.65% in 2023, and later crashed by 3090.06% in 2024.
  • Quarter analysis of 5 years shows Acadia Healthcare Company's Operating Expenses stood at $497.4 million in 2021, then grew by 18.07% to $587.2 million in 2022, then rose by 12.88% to $662.8 million in 2023, then increased by 11.07% to $736.2 million in 2024, then grew by 10.24% to $811.6 million in 2025.
  • Its Operating Expenses stands at $811.6 million for Q3 2025, versus $819.2 million for Q2 2025 and $757.0 million for Q1 2025.